Rare Disease Day is observed every year on the last day of February. In the United States, a disease is considered rare (or orphan) when it affects fewer than 200,000 people. While each condition may impact…
Team TrialX at SCOPE 2026: Sharib Khan (Co-founder & CEO), Wes Martz (Senior Director of Client Services), Beth Dickson (VP, Business Development), and Brandon Ramos (Sales Development Representative) SCOPE 2026 once again brought together leaders across…
The 17th Annual SCOPE Summit once again brought together leaders across clinical operations, digital health, patient engagement, and data innovation to shape the future of clinical research. This year, the tone was clear: the industry is…
“As we close 2025, I’m incredibly proud of what the TrialX team has built over more than 17 years of innovation and delivery. From launching our first app in 2008 with pioneers like Google Health and…
🦃 This holiday season, we’re especially grateful for partnerships that bring hope to patients and families. We are honored to power the AI-based clinical trial finder for ALK Positive, a patient-driven organization dedicated to improving the…
In 2022, OpenAI launched its first large-scale AI tool—an innovation that quickly reshaped how industries approached automation, creativity, and problem-solving. Since then, artificial intelligence has become part of everyday workflows, turning time-intensive tasks into faster, data-driven…
“Being in clinical trials required a lot of travel, which was costly and tough on my body.”– Katie Doble, cancer trial participant in Colorado For Katie, joining a clinical trial meant leaving her home state and…
